Christian Umkehrer

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 4

Top Topics

Replacement Therapy

Genome Wide Analysis

Stem Cell Transplantation

Top Venues

Nature biotechnology

Nature reviews. Cancer

Science (New York, N.Y.)

This page only lists publications with an associated author ORCID identifier.

Publications

Christian Umkehrer
Functional lineage tracing to study the clonal evolution of therapy resistance. Nature reviews. Cancer 22 (6) (2022)
Lisa Haas, Anais Elewaut, Camille L Gerard, Christian Umkehrer, Lukas Leiendecker, Malin Pedersen, Izabela Krecioch, David Hoffmann, Maria Novatchkova, Mario Kuttke, Tobias Neumann, Ines Pires da Silva, Harriet Witthock, Michel A Cuendet, Sebastian Carotta, Kevin J Harrington, Johannes Zuber, Richard A Scolyer, Georgina V Long, James S Wilmott, Olivier Michielin, Sakari Vanharanta, Thomas Wiesner, Anna C Obenauf
Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy in melanoma. Nature cancer 2 (7) (2021)
Christian Umkehrer, Felix Holstein, Laura Formenti, Julian Jude, Kimon Froussios, Tobias Neumann, Shona M Cronin, Lisa Haas, Jesse J Lipp, Thomas Rainer Burkard, Michaela Fellner, Thomas Wiesner, Johannes Zuber, Anna C Obenauf
Isolating live cell clones from barcoded populations using CRISPRa-inducible reporters. Nature biotechnology 39 (2) (2020)
Matthias Muhar, Anja Ebert, Tobias Neumann, Christian Umkehrer, Julian Jude, Corinna Wieshofer, Philipp Rescheneder, Jesse J Lipp, Veronika A Herzog, Brian Reichholf, David A Cisneros, Thomas Hoffmann, Moritz F Schlapansky, Pooja Bhat, Arndt von Haeseler, Thomas Köcher, Anna C Obenauf, Johannes Popow, Stefan L Ameres, Johannes Zuber
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis. Science (New York, N.Y.) 360 (6390) (2018)